65,437 trials
Marginal Zone Lymphoma · Follicular Lymphoma
Primary: Number of Participants With Complete Response Rate (CR) at 8 Weeks Post Single Agent Induction — 2 Participants
Treatment Resistant Depression
Primary: Improvement in Depressive Symptoms — -14.9 units on a scale
Deep Partial-thickness Burn
Primary: Number of Participants With Treatment Emergent Adverse Events (TEAEs) — 46 Participants
Type2 Diabetes
Primary: Fasting Glucose Measured Using Continuous Glucose Monitoring — 148.6; 142.1 mg/dL
Intraocular Pressure and PROSE Lens
Primary: The Goal of This Research is to Determine the Reproducibility of Measurements of Intraocular Pressure (IOP) When a Scleral Lens is on the Eye. — 24.23; 22.32; 24.52 mmHg…
Bullying
Primary: Knowledge and Confidence to Support Defenders — 33.52; 38.90 score on a scale
Obesity · Healthy
Primary: Distribution Volume Ratio (DVR) of [11C]MRB PET Imaging of Peripheral Sympathetic Nervous System — 0.13; -0.025; 0.095; -0.03 DVR
Tolerance · Adolescent Behavior · THC
Primary: Change From Baseline in Profile of Mood States (POMS) — 5.75; 12.46; 18.55; 4.08 units on a scale
Colorectal Cancer
Primary: Maximum Tolerated Dose (MTD) of Hydroxychloroquine and Entinostat in Combination With Regorafenib — 1200; 5 mg
Partial Seizures With or Without Secondary Generalization · Epilepsy
Primary: Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs) — 58.4; 57.0; 60.1; 26.6 percentage of participants
Spina Bifida · Kidney Transplant
Primary: Mean Percentage of Subjects With Adherence Behavior Greater Than or Equal to 85% From Baseline and Intervention Period (6-month) — 30.56; 42.04; 6.39; 12.14 percentage…
Anxiety · Depression · Back Pain
Primary: Adult PROMIS CAT Depression v1.0 — -1.3 T-score
Tuberculosis, Pulmonary · Tuberculosis, Multidrug-Resistant · Tuberculosis, MDR
Primary: Number of Participants With Culture Negative Status by 8 Weeks — 70; 122 Participants — p=<0.001
Stroke · Transient Ischemic Attack
Primary: Stroke Patient Education Retention Tool — 49; 52; 29; 38 Participants
HIV · Risk Reduction Behavior
Primary: Feasibility Assessed Using Change in Retention Rates — 97.5; 97.4; 97.5; 100 percentage of questionnaires returned